Skip to main content
. 2021 Nov 29;2021(11):CD013531. doi: 10.1002/14651858.CD013531.pub2

Neeb 2019.

Methods Study design: phase III, placebo‐controlled RCT
Setting: Germany
Participants 36 adults
Interventions IG: transcranial direct current stimulation for 5 days
CG: placebo
Outcomes Outcomes:
  1. High‐resolution 3D T1‐weighted MRI scans using a magnetisation‐prepared rapid gradient echo sequence

  2. Diffusion tensor imaging sequences using a single‐shot echo‐planar imaging sequence

  3. Blood oxygen level‐dependent resting‐state scans using an echo‐planar imaging sequence

  4. 1 mm isotropic T2‐weighted fluid‐attenuated inversion recovery sequence

  5. T1‐ and T2‐weighted images

Notes Funding: This study has been supported by the grant “Patientenorientierte Forschung bei CED 2014” of the “Deutsche Morbus Crohn /Colitis ulcerosa Vereinigung e.V.” (DCCV e.V.) commissioned to Magdalena Sarah Prüss.
Contact: magdalena.pruess@charite.de
We received no response from the author and were therefore unable to determine whether this study meets our inclusion criteria.